Načítá se...
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
Male breast cancer (BCa) is a rare disease accounting for less than 1% of all breast cancers and 1% of all cancers in males. The clinical management is largely extrapolated from female BCa. Several multigene assays are increasingly used to guide clinical treatment decisions in female BCa, however, t...
Uloženo v:
| Vydáno v: | NPJ Breast Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8313692/ https://ncbi.nlm.nih.gov/pubmed/34312396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-021-00301-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|